The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 04, 2025
Filed:
Feb. 25, 2022
Treatment of liver disease with mitochondrial glycerol-3-phosphate acyltransferase (gpam) inhibitors
Applicant:
Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);
Inventors:
Luca Andrea Lotta, Tarrytown, NY (US);
Niek Verweij, Tarrytown, NY (US);
Colm O'Dushlaine, Tarrytown, NY (US);
Jonathan Marchini, Tarrytown, NY (US);
Aris Baras, Tarrytown, NY (US);
Assignee:
Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); A61K 31/7088 (2006.01); A61K 38/46 (2006.01); A61P 1/16 (2006.01); C12N 15/113 (2010.01); C12Q 1/6883 (2018.01); C12Q 1/6827 (2018.01); C12Q 1/6874 (2018.01);
U.S. Cl.
CPC ...
C12N 15/1137 (2013.01); A61K 31/7088 (2013.01); A61K 38/465 (2013.01); A61P 1/16 (2018.01); C12Q 1/6883 (2013.01); C12N 2310/14 (2013.01); C12N 2310/531 (2013.01); C12Q 1/6827 (2013.01); C12Q 1/6874 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/158 (2013.01);
Abstract
The present disclosure provides methods of treating subjects having liver disease, and methods of identifying subjects having an increased risk of developing liver disease.